{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:46:19Z","timestamp":1792176379543,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the prognostic significance of intraretinal hyperreflective foci (HRF) and subretinal drusenoid deposits (SDD) as predictors of atrophy presence and progression to exudative macular neovascularisation (eMNV) in the unaffected second eye of participants with eMNV in the first eye.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Post hoc prognostic analysis on iAMD eyes from the prospective EDNA cohort. SD-OCT scans of 459 study eyes were graded for presence of HRF, SDD, and their characteristics, including location within retina (inner, outer, or both), proximity to irregular elevation of RPE (adjacent, remote or both), and SDD load (mild or moderate to severe). The cohort was subdivided in four follow up groups, iAMD without focal regions of atrophy (FoA), persistent or new onset FoA, eMNV alone and eMNV with FoA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 459 included eyes, 234 (51.0%) had HRF and 273 (60.0%) had SDD at baseline. Persistent or new onset FoA was seen in 83, 66 progressed to eMNV alone and 38 to eMNV with FoA, and 272 had no worsening of iAMD status. Presence of HRF and especially a higher SDD load were associated with a significantly faster progression to exudation. A higher SDD load doubled the hazard of progression to any eMNV compared to eyes with a mild load or without SDD. This hazard was highest in eyes with the presence of both HRF and SDD. HRF were associated with a lower BCVA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HRF and SDD are consistently observed in high risk AMD eyes and characterising their distribution and load might allow differentiation of their contributions to risk of progression to late stage features of atrophy and exudation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-026-04617-8","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T18:21:09Z","timestamp":1784398869000},"page":"2360-2366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperreflective foci and subretinal drusenoid deposits as predictors\u00a0of exudation in intermediate AMD eyes with contralateral neovascular AMD"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8082-4813","authenticated-orcid":false,"given":"Enrico","family":"Bernardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-3734","authenticated-orcid":false,"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Muldrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9413-2669","authenticated-orcid":false,"given":"Ruth E.","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8948-3691","authenticated-orcid":false,"given":"David M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3447-2359","authenticated-orcid":false,"given":"Martin","family":"Zinkernagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-0381","authenticated-orcid":false,"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5243-7536","authenticated-orcid":false,"given":"Lajos","family":"Csincsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"4617_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-66014-7_1","volume":"1256","author":"TDL Keenan","year":"2021","unstructured":"Keenan TDL, Cukras CA, Chew EY. Age-related macular degeneration: epidemiology and clinical aspects. Adv Exp Med Biol. 2021;1256:1\u201331.","journal-title":"Adv Exp Med Biol"},{"key":"4617_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","volume":"7","author":"M Fleckenstein","year":"2021","unstructured":"Fleckenstein M, Keenan T, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, et al. Age-related macular degeneration. Nat Rev Dis Prim. 2021;7:31.","journal-title":"Nat Rev Dis Prim"},{"key":"4617_CR3","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman SR, Bourne R, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1221\u2013e1234.","journal-title":"Lancet Glob Health"},{"key":"4617_CR4","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106\u2013116.","journal-title":"Lancet Glob Health"},{"key":"4617_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/eye.2016.227","volume":"31","author":"U Schmidt-Erfurth","year":"2017","unstructured":"Schmidt-Erfurth U, Klimscha S, Waldstein SM, Bogunovi\u0107 H. A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration. Eye. 2017;31:26\u201344.","journal-title":"Eye"},{"key":"4617_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ajo.2025.01.011","volume":"272","author":"L Csincsik","year":"2025","unstructured":"Csincsik L, Cheung CMG, Bannon F, Peto T, Chakravarthy U. Agreement Between Color, Fluorescein Angiography, and Spectral Domain Optical Coherence Tomography in the Detection of Macular Fibrosis in Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2025;272:126\u201335.","journal-title":"Am J Ophthalmol"},{"key":"4617_CR7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.oret.2020.01.012","volume":"4","author":"U Chakravarthy","year":"2020","unstructured":"Chakravarthy U, Bailey CC, Scanlon PH, McKibbin M, Khan RS, Mahmood S, et al. Progression from Early\/Intermediate to Advanced Forms of Age-Related Macular Degeneration in a Large UK Cohort: Rates and Risk Factors. Ophthalmol Retin. 2020;4:662\u201372.","journal-title":"Ophthalmol Retin"},{"key":"4617_CR8","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00417-017-3693-y","volume":"255","author":"J Lei","year":"2017","unstructured":"Lei J, Balasubramanian S, Abdelfattah NS, Nittala MG, Sadda SR. Proposal of a simple optical coherence tomography-based scoring system for progression of age-related macular degeneration. Graefe\u2019s Arch Clin Exp Ophthalmol. 2017;255:1551\u20138.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"4617_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ophtha.2010.08.010","volume":"118","author":"J Ho","year":"2011","unstructured":"Ho J, Witkin AJ, Liu J, Chen Y, Fujimoto JG, Schuman JS, et al. Documentation of Intraretinal Retinal Pigment Epithelium Migration via High-Speed Ultrahigh-Resolution Optical Coherence Tomography. Ophthalmology. 2011;118:687\u201393.","journal-title":"Ophthalmology"},{"key":"4617_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6096017","volume":"2021","author":"S Fragiotta","year":"2021","unstructured":"Fragiotta S, Abdolrahimzadeh S, Dolz-Marco R, Sakurada Y, Gal-Or O, Scuderi G. Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications. J Ophthalmol. 2021;2021:6096017.","journal-title":"J Ophthalmol"},{"key":"4617_CR11","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1167\/iovs.18-24143","volume":"59","author":"M Nassisi","year":"2018","unstructured":"Nassisi M, Fan W, Shi Y, Lei J, Borrelli E, Ip M, et al. Quantity of Intraretinal Hyperreflective Foci in Patients With Intermediate Age-Related Macular Degeneration Correlates With 1-Year Progression. Invest Ophthalmol Vis Sci. 2018;59:3431\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4617_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.oret.2026.02.011","volume":"10","author":"E Bernardi","year":"2026","unstructured":"Bernardi E, Chakravarthy U, Muldrew KA, Hogg RE, Wright DM, Zinkernagel M, et al. Tomographic Biomarkers Differ by Progression Risk to Late Macular Degeneration. Ophthalmol Retin. 2026;10:684\u20136.","journal-title":"Ophthalmol Retin"},{"key":"4617_CR13","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1007\/s00417-023-06127-9","volume":"261","author":"D Kang","year":"2023","unstructured":"Kang D, Lee YJ, Nam KT, Choi M, Yun C. Hyperreflective foci distribution in eyes with dry age-related macular degeneration with subretinal drusenoid deposits. Graefes Arch Clin Exp Ophthalmol. 2023;261:2821\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4617_CR14","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1007\/s00417-023-06180-4","volume":"261","author":"A Verma","year":"2023","unstructured":"Verma A, Corradetti G, He Y, Nittala MG, Nassisi M, Velaga SB, et al. Relationship between the distribution of intra-retinal hyper-reflective foci and the progression of intermediate age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2023;261:3437\u201347.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4617_CR15","first-page":"511","volume":"13","author":"G Mimoun","year":"1990","unstructured":"Mimoun G, Soubrane G, Coscas G. Macular drusen]. J Fr Ophtalmol. 1990;13:511\u201330.","journal-title":"J Fr Ophtalmol"},{"key":"4617_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ophtha.2009.07.014","volume":"117","author":"SA Zweifel","year":"2010","unstructured":"Zweifel SA, Spaide RF, Curcio CA, Malek G, Imamura Y. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology. 2010;117:303\u2013312.e301.","journal-title":"Ophthalmology"},{"key":"4617_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.exer.2008.07.010","volume":"87","author":"M Rudolf","year":"2008","unstructured":"Rudolf M, Malek G, Messinger JD, Clark ME, Wang L, Curcio CA. Sub-retinal drusenoid deposits in human retina: Organization and composition. Exp Eye Res. 2008;87:402\u20138.","journal-title":"Exp Eye Res"},{"key":"4617_CR18","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.3390\/jcm12247728","volume":"12","author":"E Krytkowska","year":"2023","unstructured":"Krytkowska E, Olejnik-Wojciechowska J, Grabowicz A, Safranow K, Machali\u0144ska A. Association between Subretinal Drusenoid Deposits and Age-Related Macular Degeneration in Multimodal Retinal Imaging. J Clin Med. 2023;12:7728.","journal-title":"J Clin Med"},{"key":"4617_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.oret.2023.10.006","volume":"8","author":"L Csincsik","year":"2024","unstructured":"Csincsik L, Muldrew KA, Bettiol A, Wright DM, Rosenfeld PJ, Waheed NK, et al. The Double Layer Sign Is Highly Predictive of Progression to Exudation in Age-Related Macular Degeneration. Ophthalmol Retin. 2024;8:234\u201345.","journal-title":"Ophthalmol Retin"},{"key":"4617_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.oret.2022.11.006","volume":"7","author":"C Duic","year":"2023","unstructured":"Duic C, Pfau K, Keenan T, Wiley H, Thavikulwat A, Chew EY, et al. Hyperreflective Foci in Age-Related Macular Degeneration are Associated with Disease Severity and Functional Impairment. Ophthalmol Retin. 2023;7:307\u201317.","journal-title":"Ophthalmol Retin"},{"key":"4617_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/iovs.64.1.20","volume":"64","author":"M Sa\u00dfmannshausen","year":"2023","unstructured":"Sa\u00dfmannshausen M, Vaisband M, von der Emde L, Sloan KR, Hasenauer J, Holz FG, et al. Hyper-Reflective Foci in Intermediate Age-Related Macular Degeneration: Spatial Abundance and Impact on Retinal Morphology. Invest Ophthalmol Vis Sci. 2023;64:20.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4617_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/IAE.0000000000000645","volume":"36","author":"H Lee","year":"2016","unstructured":"Lee H, Ji B, Chung H, Kim HC. Correlation Between Optical Coherence Tomographic Hyperreflective Foci and Visual Outcomes After Anti-Vegf Treatment in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy. Retina. 2016;36:465\u201375.","journal-title":"Retina"},{"key":"4617_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-023-00461-0","volume":"9","author":"TYA Liu","year":"2023","unstructured":"Liu TYA, Wang J, Csaky KG. Correlation between hyperreflective foci and visual function testing in eyes with intermediate age-related macular degeneration. Int J Retin Vitreous. 2023;9:24.","journal-title":"Int J Retin Vitreous"},{"key":"4617_CR24","doi-asserted-by":"publisher","first-page":"100173","DOI":"10.1016\/j.xops.2022.100173","volume":"2","author":"EM Lad","year":"2022","unstructured":"Lad EM, Fang V, Tessier M, Rautanen A, Gayan J, Stinnett SS, et al. Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients. Ophthalmol Sci. 2022;2:100173.","journal-title":"Ophthalmol Sci"},{"key":"4617_CR25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris","year":"2013","unstructured":"Ferris FL, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844\u201351.","journal-title":"Ophthalmology"},{"key":"4617_CR26","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1167\/iovs.08-3064","volume":"50","author":"JM Seddon","year":"2009","unstructured":"Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009;50:2044\u201353.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4617_CR27","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.ophtha.2011.04.029","volume":"118","author":"JM Seddon","year":"2011","unstructured":"Seddon JM, Reynolds R, Yu Y, Daly MJ, Rosner B. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology. 2011;118:2203\u201311.","journal-title":"Ophthalmology"},{"key":"4617_CR28","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1167\/iovs.14-15841","volume":"56","author":"JM Seddon","year":"2015","unstructured":"Seddon JM, Silver RE, Kwong M, Rosner B. Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates. Invest Ophthalmol Vis Sci. 2015;56:2192\u2013202.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4617_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ophtha.2013.08.011","volume":"121","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, Brown DM, Chong V, Nguyen QD, et al. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. Ophthalmology. 2014;121:193\u2013201.","journal-title":"Ophthalmology"},{"key":"4617_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2025.100798","volume":"5","author":"U Chakravarthy","year":"2025","unstructured":"Chakravarthy U, Chaudhary V, Sadda SR, Tan CS, Vujosevic S, Fauser S, et al. Effect of Faricimab versus Aflibercept on Hyperreflective Foci in Patients with Diabetic Macular Edema from the YOSEMITE\/RHINE Trials. Ophthalmol Sci. 2025;5:100798.","journal-title":"Ophthalmol Sci"},{"key":"4617_CR31","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1167\/iovs.11-9063","volume":"53","author":"G Querques","year":"2012","unstructured":"Querques G, Canou\u00ef-Poitrine F, Coscas F, Massamba N, Querques L, Mimoun G, et al. Analysis of progression of reticular pseudodrusen by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53:1264\u201370.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4617_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/bjophthalmol-2020-316004","volume":"105","author":"S Thiele","year":"2021","unstructured":"Thiele S, Nadal J, Pfau M, Sa\u00dfmannshausen M, Fleckenstein M, Holz FG, et al. Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression. Br J Ophthalmol. 2021;105:239\u201345.","journal-title":"Br J Ophthalmol"},{"key":"4617_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1167\/iovs.61.6.11","volume":"61","author":"GS Reiter","year":"2020","unstructured":"Reiter GS, Told R, Schranz M, Baumann L, Mylonas G, Sacu S, et al. Subretinal Drusenoid Deposits and Photoreceptor Loss Detecting Global and Local Progression of Geographic Atrophy by SD-OCT Imaging. Invest Ophthalmol Vis Sci. 2020;61:11.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04617-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04617-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04617-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:55:37Z","timestamp":1792173337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04617-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":33,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4617"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04617-8","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article the Abstract Conclusion section has been included in the grey box.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have completed and submitted the ICMJE disclosures form. The authors have made the following disclosure(s): E. B.: Clinical grant \u2013 Swiss Society of Ophthalmology (SSO). K.A.M.: Institutional grant \u2013 Boehringer Ingelheim International GmbH, Germany. T.P.: Grant support \u2013 Queen\u2019s University Belfast, Boehringer Ingelheim International GmbH; Speakers and consultancy fee \u2013 Roche, Apellis, Abbvie, Novartis, Heidelberg, OPTOS, Optomed, Boehringen-Ingelheim. U.C.: Grant support \u2013 Queen\u2019s University Belfast, Boehringer Ingelheim International GmbH; Personal fees \u2013 Aavantgarde, Adverum, Alnylam, Annexon, Aviceda, Apellis, Eypoint, Exonate, Roche, Nanoscope, Ocular Therapeutix, M.Z.: Speakers and consultancy fee \u2013 Bayer, Janssen, Oculis, Alcon, Roche, Novartis, Sandoz, Annexon, Abbvie, Novago, Astellas. The other authors have no proprietary or commercial interest in any materials discussed in this article. The sponsor or funding organisation participated in data collection and data management. Tunde Peto is a member of the Eye editorial board.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}